Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications

BACKGROUND: The National Medical Products Administration (NMPA) in China has set to advance the regulatory capacity of traditional Chinese medicines (TCMs) with the adoption of regulatory science (RS). However, the priority of actions at the interface of RS and TCMs were yet to be defined. This rese...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Chin Med
Main Authors: Liang, Zuanji, Lai, Yunfeng, Li, Meng, Shi, Junnan, Lei, Chi Ieong, Hu, Hao, Ung, Carolina Oi Lam
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2021
נושאים:
Review
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7884970/
https://ncbi.nlm.nih.gov/pubmed/33593397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13020-021-00433-2
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים